NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. doi: 10.36255/exonpublications.prostatecancer.diagnostics.2021
| Age (years) | Serum PSA reference range ng/ml |
|---|---|
| 40 – 49 | 0 – 2.5 |
| 50 – 59 | 0 – 3.5 |
| 60 – 69 | 0 – 4.5 |
| 70 – 79 | 0 – 6.5 |
Licence: This open access article is licenced under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/
Whiting D, Bott SRJ. Current Diagnostics for Prostate Cancer. In: Bott SRJ, Ng KL, editors. Prostate Cancer [Internet]. Brisbane (AU): Exon Publications; 2021 May 27. Table 1, Recommended age specific serum PSA reference ranges () doi: 10.36255/exonpublications.prostatecancer.diagnostics.2021
More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET/CT.
Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med. 2019 Jan-Apr; 22(1):6-9. Epub 2019 Mar 7.
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JWF, Chapple CR, Montorsi F, Mottet N, Roobol MJ, Sønksen J, et al. Eur Urol. 2019 Aug; 76(2):142-150. Epub 2019 May 12.
Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
Huncharek M, Muscat J. Cancer Invest. 1995; 13(1):31-5.Review PSA Based Biomarkers, Imagistic Techniques and Combined Tests for a Better Diagnostic of Localized Prostate Cancer.
Munteanu VC, Munteanu RA, Gulei D, Schitcu VH, Petrut B, Berindan Neagoe I, Achimas Cadariu P, Coman I. Diagnostics (Basel). 2020 Oct 10; 10(10). Epub 2020 Oct 10.
